Xenon Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 04:37 pm EST
Xenon Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 48.46 million compared to USD 37.15 million a year ago. Basic loss per share from continuing operations was USD 0.73 compared to USD 0.57 a year ago.
For the nine months, net loss was USD 137.65 million compared to USD 87.98 million a year ago. Basic loss per share from continuing operations was USD 2.09 compared to USD 1.49 a year ago.